At Yonge & 7 Dental, we take preventive practice seriously, especially for cancer diseases that normally cannot been seen or detected with conventional methods. Thus, we introduce VELscope technology as a new way to screen for early signs of abnormalities.
The VELscope is a handheld device that emits a harmless, bright blue light which is used to inspect the mouth and tongue. The device is extremely sensitive to abnormal tissue changes and the distinctive blue-spectrum light causes the soft tissue of the mouth to naturally fluoresce. Healthy tissues fluoresce in distinct patterns. Abnormal cells from disease, such as neoplastic lesions, and fungal, viral or bacterial infections or from trauma, fluoresce in a very different pattern.
We use the VELscope device to supplement the traditional intra and extra oral head and neck exam, to help detect abnormal oral tissue that are not apparent or sometimes not even visible with the naked eye alone. Exams can be more thorough and any suspicious areas can be quickly investigated for confirmation of oral disease.
The VELscope device is an imaging modality which is extremely sensitive to tissue changes. Its use in everyday practice can provide timely information to dentists and hygienists to enable earlier detection of abnormal tissue and provide better outcomes for patients
The statistics are highly favourable: when discovered early the 5-year survival rate for oral cancer patients is about 83%. Unfortunately, most cases of oral cancer are discovered in late stages, when the five-year survival rate drops to around 50 percent.
Detecting oral abnormalities early leads to more treatment options.
Cleared by the FDA, and approved by Health Canada, and the World Health Organization, the award-winning VELscope is the world's most widely used adjunctive for the discovery of